SCHEMBL5501103

SCHEMBL5501103

Oc1ccc(Nc2ncc(-c3cccs3)cn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
VCP P55072 2/20 0.52
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 1/20 0.52
SYK P43405 4/20 0.46
NPC1 O15118 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP2E1 P05181 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2A6 P11509 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2B6 P20813 1/20 0.44
AURKA O14965 8/20 0.43
CDK1 P06493 2/20 0.43
KDR P35968 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
FYN P06241 1/20 0.41
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5499768 0.86 MAPT (0.44) MAPTVCPMEN1ALDH1A1KMT2A
SCHEMBL5501093 0.83 CSNK2A1 (0.54) MAPTMEN1KMT2ASYKNPC1
SCHEMBL5495510 0.82 HDAC3 (0.49) MAPTMEN1ALDH1A1KMT2ASYK
SCHEMBL10976554 0.77 MEN1 (0.55) MAPTVCPMEN1ALDH1A1KMT2A
SCHEMBL5502163 0.76 MAPT (0.53) MAPTMEN1KMT2ASYKNPC1
SCHEMBL5499637 0.75 SYK (0.50) MAPTMEN1KMT2ASYKSMN1; SMN2
SCHEMBL10726997 0.74 FYN (0.58) MAPTVCPMEN1ALDH1A1KMT2A
SCHEMBL5504570 0.74 RHOA (0.53) MAPTMEN1ALDH1A1KMT2ANPC1
SCHEMBL5496551 0.74 CTSC (0.44) SYKCYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL5495323 0.73 MAP3K5 (0.55) MAPTMEN1ALDH1A1KMT2ASYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US claimed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP claimed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO claimed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP disclosed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293484-A1 Thiophene Heteroaryl Amines TTK, CHEK2, ABL1 MAPT 1768/4885VCP 2120/4885MEN1 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.